BioSpace News Archive

Biotech Bay

BioMarin to Present Findings from Ongoing Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the World Federation of Hemophilia 2022 World Congress, May 8-11, 2022, Including Five Platform Presentations

BioMarin Pharmaceutical Inc. today announced five platform presentations and one poster presentation on valoctocogene roxaparvovec, an investigational gene therapy for the treatment of adults with severe hemophilia A, at the World Federation of Hemophilia (WFH) 2022 World Congress from May 8-11 in Montreal, Canada.

May 5, 2022
·
7 min read
Lone Star Bio

Genprex Issues Shareholder Letter and Provides 2022 Corporate Update

Genprex, Inc. announced that it has issued a shareholder letter and corporate update outlining the Company’s recent progress in its clinical development programs and key milestones and achievements for 2022 and beyond.

May 5, 2022
·
5 min read
Researchers at the Gwangju Institute of Science and Technology Develop Deep Learning Model to Predict Adverse Drug-Drug Interactions

The intake of multiple drugs can result in adverse health effects due to unexpected drug-drug interactions.

May 5, 2022
·
3 min read
Pharm Country

MPAACT Consortium Unites Industry and Academia to Establish Measurable Residual Disease as a Surrogate Endpoint in Acute Myeloid Leukemia Drug Development

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the Measurable residual disease Partnership and Alliance in Acute myeloid leukemia Clinical Treatment, is advancing efforts to establish measurable residual disease as a surrogate endpoint for overall survival in the treatment of acute myeloid leukemia.

May 5, 2022
·
6 min read